SuperworthArcadia Biosciences profit margin RKDA
Gross, operating and net profit as a share of revenue over the last twelve months, from 2020.
- Net margin, 12 months
- n/m
- not a meaningful number
- Operating margin, 12 months
- −80.1%
- Peer median
- −24.5%
Arcadia Biosciences' net margin works out at −235% over the last twelve months, but it is not a meaningful number: a margin outside minus 100% to 100% is moved by items that are not sales.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −48.1% | −51.4% | 36.2% |
| FY2024 | n/a | −72.3% | 41.3% |
| FY2023 | n/a | n/a | 49.3% |
| FY2022 | n/a | n/a | 4.9% |
| FY2021 | n/a | n/a | −28.4% |
| FY2020 | −58.0% | n/a | 35.3% |
| FY2019 | n/a | n/a | 24.2% |
| FY2018 | n/a | n/a | 54.8% |
| FY2017 | n/a | n/a | 93.0% |
| FY2016 | n/a | n/a | 71.9% |
| FY2015 | n/a | n/a | 83.5% |
| FY2014 | n/a | n/a | 71.4% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | n/a | n/a | −80.1% | |
| Q1 FY26 | n/a | n/a | −80.0% | |
| Q4 FY25 | −48.1% | n/a | −51.4% | |
| Q3 FY25 | −98.0% | n/a | −65.8% | |
| Q2 FY25 | n/a | n/a | −74.1% | |
| Q1 FY25 | −38.3% | n/a | −29.1% | |
| Q4 FY24 | n/a | n/a | −72.3% | |
| Q3 FY24 | n/a | n/a | −55.6% | |
| Q2 FY24 | n/a | n/a | −50.3% | |
| Q1 FY24 | n/a | n/a | n/a | |
| Q4 FY23 | n/a | n/a | n/a | |
| Q3 FY23 | n/a | n/a | n/a |
Against its peers
Companies in Oil & Gas Exploration & Production nearest Arcadia Biosciences' size, closest first, today.
| Company | Profit margin |
|---|---|
| RKDAArcadia Biosciences | n/m |
| TPETTrio Petroleum | n/m |
| BRNBarnwell Industries | −46.7% |
| MXCMexco Energy | 23.3% |
| CKXCKX Lands | n/m |
| EONREON Resources | −91.4% |
| PROPPrairie Operating | −13.0% |
| AGIGAbundia Global Impact | n/m |
| BATLBattalion Oil | −24.5% |
| NRTNorth European Oil Royalty Trust | n/m |
| BSINBig Sky Industrial | n/m |
| Peer median | −24.5% |
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Arcadia Biosciences
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.